![Carsten Brunn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carsten Brunn
Directeur Général chez
Cartesian Therapeutics, Inc.
Fortune : 449 663 $ au 31/05/2026
Profil
Carsten Brunn is currently President & Chief Executive Officer at Cartesian Therapeutics, Inc. (United States) since 2023, Chairman, President & Chief Executive Officer at Cartesian Therapeutics, Inc. starting in 2025, and Director at Biotechnology Innovation Organization.
Former roles include President, Chief Executive Officer & Director at Selecta Biosciences, Inc., Chairman-Japan Region at European Federation of Pharmaceutical Industries & Assns from 2014 to 2016, Director at Surface Oncology, Inc. from 2022 to 2023, President-Americas Region at Bayer Pharmaceuticals Corp., and President at Bayer Yakuhin Ltd. from 2013 to 2016.
Education includes graduate studies at the University of Freiburg and a doctorate from the University of Hamburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,2% | 14/04/2026 | 59 637 ( 0,2% ) | 449 663 $ | 31/05/2026 |
Postes actifs de Carsten Brunn
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases | Directeur Général | 01/11/2023 |
Anciens postes connus de Carsten Brunn
| Sociétés | Poste | Fin |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Directeur/Membre du Conseil | 08/09/2023 |
Bayer Yakuhin Ltd.
 Bayer Yakuhin Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and diagnostic substances | President | 01/12/2016 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Corporate Officer/Principal | 01/12/2016 |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - |
| CARTESIAN THERAPEUTICS, INC. | Directeur Général | - |
Formation de Carsten Brunn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Bayer Pharmaceuticals Corp. | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer Yakuhin Ltd.
Bayer Yakuhin Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and diagnostic substances | Health Technology |
University of Hamburg
 University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases | Commercial Services |
